New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aerovate Therapeutics, Inc.
AVTE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

61M

Biotechnology

Next Earning date - 11 Nov 2024

61M

Biotechnology

Next Earning date - 11 Nov 2024

2.11USD
Shape0.01 ( 0.48%)
Market Open
favorite-chart

Relative Strenght

23
favorite-chart

Volume Buzz

-40%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

93%

Quote Panel

Shape
Updated October 25, 2024
1W -9.83 % 1M 1.44 % 3M 4.98 % 1Y -79.00 %

Key Metrics

Shape
  • Market Cap

    60.91M


  • Shares Outstanding

    28.87M


  • Share in Float

    19.58M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    2.11


  • Average Volume

    240318


  • Beta

    1.035


  • Range

    1.25-32.415


  • Industry

    Biotechnology


  • Website

    https://aerovatetx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

445.75x

P/S Ratio

0.64x

P/B Ratio

0.0

Debt/Equity

-64659.6%

Net Margin

$-3.0

EPS

How AVTE compares to sector?

P/E Ratio

Relative Strength

Shape

AVTE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.00

Shape-16%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

downgrade

Previous: Overweight

2024-06-18

Now: Equal-Weight

Cowen & Co.

downgrade

Previous: Not converted

2024-06-17

Now: Hold

Guggenheim

downgrade

Previous: Not converted

2024-06-17

Now: Neutral

Jefferies

downgrade

Previous: Not converted

2024-06-17

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.56
vs -0.26

Q4.22

arrow
arrow

N/A

-0.61
vs -0.34

Q1.23

arrow
arrow

N/A

-0.67
vs -0.45

Q2.23

arrow
arrow

N/A

-0.76
vs -0.49

Q3.23

arrow
arrow

N/A

-0.71
vs -0.56

Q4.23

arrow
arrow

N/A

-0.74
vs -0.61

Q1.24

arrow
arrow

N/A

-0.83
vs -0.67

Q2.24

arrow
arrow

N/A

-0.86
vs -0.76

Q3.24

arrow
arrow

N/A

-0.59
vs -0.71

Q4.24

arrow
arrow

N/A

-0.54
vs -0.74

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

136K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-9%

-0.09
vs -0.08

Q4.22

arrow
arrow

-12%

-0.12
vs -0.09

Q1.23

arrow
arrow

-14%

-0.14
vs -0.12

Q2.23

arrow
arrow

-13%

-0.13
vs -0.14

Q3.23

arrow
arrow

-16%

-0.16
vs -0.13

Q4.23

arrow
arrow

-19%

-0.19
vs -0.16

Q1.24

arrow
arrow

-26%

-0.26
vs -0.19

Q2.24

arrow
arrow

-26%

-0.26
vs -0.26

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

54

54
vs 49

10%

Q4.22

arrow
arrow

69

69
vs 54

28%

Q1.23

arrow
arrow

65

65
vs 69

-6%

Q2.23

arrow
arrow

60

60
vs 65

-8%

Q3.23

arrow
arrow

58

58
vs 60

-3%

Q4.23

arrow
arrow

63

63
vs 58

9%

Q1.24

arrow
arrow

79

79
vs 63

25%

Q2.24

arrow
arrow

93

93
vs 79

18%

Earnings Growth

Latest News